Calycosin suppressed the proliferation of ER‐positive and negative breast cancer cells through acting WDR7‐7‐GPR30 signaling via reducing phosphorylation of therapeutic targeting protein including SRC, EGFR, ERK1/2, and Akt in a dose‐dependent manner.49 Here, AKT1 is linked to breast cancer.